{"Name":"Amarantus BioSciences","perma":"amarantus-biosciences","BasicInfo":{"funded":"2008-01-01","isClosed":false,"closed":null,"short":"Amarantus BioSciences develops treatments for diseases associated with the dysfunction of biological pathways."},"FundingRounds":[{"funding_type":"venture","series":null,"announcedDate":"2014-11-17","moneyRaised":3000000},{"funding_type":"seed","series":null,"announcedDate":"2013-08-28","moneyRaised":1299327}],"Acquisitions":[],"AcquiredBy":{"price":null,"paymentType":null,"announcedDate":"2016-05-12","completedDate":null,"acquisitionType":"Acquisition","acquirer":"Avant Diagnostics"},"IPO":null,"Investments":[],"Products":[],"CurrentTeam":[{"title":"CEO, Chairman","started":null,"ended":null,"firstName":"Martin","lastName":"D. Cleary"},{"title":"CFO","started":null,"ended":null,"firstName":"Marc","lastName":"E. Faerber"},{"title":"COO","started":null,"ended":null,"firstName":"Gerald","lastName":"E. Commissiong"}],"PastTeam":[{"title":"Co-Founder & CBO","started":"2008-01-01","ended":"2011-06-01","firstName":null,"lastName":null}]}
